Lh. Pang et al., NOVEL DITERPENOID LABDANE FROM SIDERITIS-JAVALAMBRENSIS INHIBITS EICOSANOID GENERATION FROM STIMULATED MACROPHAGES BUT ENHANCES ARACHIDONATE RELEASE, Biochemical pharmacology, 51(6), 1996, pp. 863-868
The diterpenoid ent-8 alpha-hydroxy-labda-13(16),14-dien (''labdane F2
'') was obtained from an anti inflammatory extract of Sideritis javala
mbrensis. Labdane F2 inhibited prostaglandin E(2) generation in cultur
ed mouse peritoneal macrophages, treated with zymosan, ionophore A2318
7, or arachidonic acid itself, and in J774 macrophage-like cells activ
ated by bacterial lipopolysaccharide (LPS). The mechanism was investig
ated by prelabelling the macrophages with radiolabelled arachidonic ac
id or oleic acid, followed by cell activation in the presence or absen
ce of nontoxic concentrations of labdane F2. Surprisingly, under those
conditions in which reduced PGE(2) generation was observed, labdane F
2 consistently enhanced the release of labelled fatty acid, in a manne
r similar to that displayed by thimerosal, a known acyl-CoA:lysolecith
in transferase inhibitor. Labdane F2, therefore, appears to possess 2
mutually opposing actions on the eicosanoid system in macrophages: pot
entiation of delivery of substrate following cell activation, followed
by inhibition of conversion of substrate to product. rc was also foun
d that nontoxic concentrations of labdane F2 reduced the expression of
the inducible isoforms of cyclooxygenase and nitric oxide synthase in
LPS-treated J774 cells. Thus, this anti-inflammatory diterpenoid labd
ane possesses a diverse array of effects impinging on enzyme pathways
involved in eicosanoid generation and other inflammatory pathways in m
acrophages.